Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gastric Cancer

  Free Subscription

Articles published in
Int J Cancer
    December 2023
  1. SASAHARA M, Kanda M, Tanaka C, Shimizu D, et al
    Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth via BCL-2-mediated intrinsic apoptosis.
    Int J Cancer. 2023 Dec 27. doi: 10.1002/ijc.34831.
    >> Share

  2. ZHANG Q, Zhou Y, Song L, Fang W, et al
    China special issue on gastrointestinal tumors-Improved survival after multidisciplinary team decision for patients with advanced gastrointestinal cancer: A multicenter, noninterventional, controlled study.
    Int J Cancer. 2023;153:1885-1893.
    >> Share

    November 2023
  3. GOETZE TO, Stein A, Lorenzen S, Habibzada T, et al
    Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy.
    Int J Cancer. 2023;153:1726-1733.
    >> Share

  4. RIJKEN A, Pape M, Simkens GA, de Hingh IHJT, et al
    Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
    Int J Cancer. 2023 Nov 2. doi: 10.1002/ijc.34780.
    >> Share

    October 2023
  5. FAN XH, Zhang Y, Wang P, Song QQ, et al
    A noninvasive multianalytical approach establishment for risk assessment and gastric cancer screening.
    Int J Cancer. 2023 Oct 16. doi: 10.1002/ijc.34739.
    >> Share

    September 2023
  6. LLACH J, Salces I, Guerra A, Penas B, et al
    Endoscopic surveillance for familial intestinal gastric cancer in low-incidence areas: An effective strategy.
    Int J Cancer. 2023 Sep 7. doi: 10.1002/ijc.34714.
    >> Share

  7. PALOMAR-CROS A, Straif K, Romaguera D, Aragones N, et al
    Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain).
    Int J Cancer. 2023;153:979-993.
    >> Share

    August 2023
  8. CHENG L, Chang Y, Xia Z, Liu Y, et al
    Remote modulation of WWOX by an intronic variant associated with survival of Chinese gastric cancer patients.
    Int J Cancer. 2023 Aug 24. doi: 10.1002/ijc.34703.
    >> Share

  9. CAO F, Sun H, Yang Z, Bai Y, et al
    Multiple approaches revealed MGc80-3 as a somatic hybrid with HeLa cells rather than a gastric cancer cell line.
    Int J Cancer. 2023 Aug 6. doi: 10.1002/ijc.34677.
    >> Share

    July 2023
  10. GOETZE TO, Hofheinz RD, Gaiser T, Schmalenberg H, et al
    Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM.
    Int J Cancer. 2023;153:153-163.
    >> Share

    March 2023
  11. GHASEMI-KEBRIA F, Semnani S, Fazel A, Etemadi A, et al
    Esophageal and gastric cancer incidence trends in Golestan, Iran: an age-period-cohort analysis 2004-2018.
    Int J Cancer. 2023 Mar 21. doi: 10.1002/ijc.34518.
    >> Share

  12. KUIJPER SC, Pape M, Haj Mohammad N, van Voorthuizen T, et al
    SOURCE beyond first-line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first-line palliative systemic therapy.
    Int J Cancer. 2023;152:1202-1209.
    >> Share

  13. XI J, Li Y, Zhang H, Bai Z, et al
    Dynamic variations of the gastric microbiota: Key therapeutic points in the reversal of Correa's cascade.
    Int J Cancer. 2023;152:1069-1084.
    >> Share

  14. MOHRING C, Manczak A, Timotheou A, Sadeghlar F, et al
    Perioperative Therapy with Flot4 Significantly Increases Survival in Patients with Gastroesophageal and Gastric Cancer in A Large Real-World Cohort.
    Int J Cancer. 2023 Mar 15. doi: 10.1002/ijc.34511.
    >> Share

  15. KUIJPER SC, Pape M, Vissers PAJ, Jeene PM, et al
    Trends in best-case, typical and worst-case survival scenarios of patients with non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Mar 1. doi: 10.1002/ijc.34488.
    >> Share

    February 2023
  16. PAPE M, Kuijper SC, Vissers PAJ, Ruurda JP, et al
    Conditional relative survival in non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Feb 25. doi: 10.1002/ijc.34480.
    >> Share

  17. ZHANG P, Gu Y, Wang J, Lv K, et al
    Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer.
    Int J Cancer. 2023 Feb 17. doi: 10.1002/ijc.34474.
    >> Share

  18. LIU T, Bai Y, Lin X, Li W, et al
    First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis.
    Int J Cancer. 2023;152:749-760.
    >> Share

    December 2022
  19. CHEN M, Chen K, Hou H, Li W, et al
    Incidence and mortality trends in gastric cancer in the United States, 1992-2019.
    Int J Cancer. 2022 Dec 23. doi: 10.1002/ijc.34415.
    >> Share

    November 2022
  20. YANG H, Wang XK, Wang JB, Zhao FH, et al
    Combined risk factors and risk of upper gastrointestinal cancer mortality in the Linxian general population.
    Int J Cancer. 2022;151:1462-1473.
    >> Share

    August 2022
  21. LEE SH, Lee Y, Jang HJ
    Deep learning captures selective features for discrimination of microsatellite instability from pathologic tissue slides of gastric cancer.
    Int J Cancer. 2022 Aug 19. doi: 10.1002/ijc.34251.
    >> Share

    June 2022
  22. QIAN Y, Zhai E, Chen S, Liu Y, et al
    Single-cell RNA-seq dissecting heterogeneity of tumor cells and comprehensive dynamics in tumor microenvironment during lymph nodes metastasis in gastric cancer.
    Int J Cancer. 2022 Jun 18. doi: 10.1002/ijc.34172.
    >> Share

  23. WANG S, Zheng R, Arnold M, Abnet C, et al
    Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype.
    Int J Cancer. 2022 Jun 9. doi: 10.1002/ijc.34158.
    >> Share

    April 2022
  24. COLLATUZZO G, Etemadi A, Sotoudeh M, Nikmanesh A, et al
    Meat consumption and risk of esophageal and gastric cancer in the Golestan Cohort Study, Iran.
    Int J Cancer. 2022 Apr 30. doi: 10.1002/ijc.34056.
    >> Share

    March 2022
  25. WU F, Yang L, Hao Y, Zhou B, et al
    Oral and gastric microbiome in relation to gastric intestinal metaplasia.
    Int J Cancer. 2022;150:928-940.
    >> Share

    November 2021
  26. QU Y, Wang X, Bai S, Niu L, et al
    The effects of TNF-alpha/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.
    Int J Cancer. 2021 Nov 11. doi: 10.1002/ijc.33873.
    >> Share

  27. PEREIRA C, Park JH, Campelos S, Gullo I, et al
    Comparison of East-Asia and West-Europe cohorts explains disparities in survival outcomes and highlights predictive biomarkers of early gastric cancer aggressiveness.
    Int J Cancer. 2021 Nov 9. doi: 10.1002/ijc.33872.
    >> Share

  28. HOGNER A, Al-Batran SE, Siveke JT, Lorenz M, et al
    Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: a randomized phase-II study - the PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510.
    Int J Cancer. 2021 Nov 6. doi: 10.1002/ijc.33864.
    >> Share

  29. GU J, Xie S, Wang S, Xue L, et al
    Surveillance of premalignant gastric cardia lesions: A population-based prospective cohort study in China.
    Int J Cancer. 2021;149:1639-1648.
    >> Share

    October 2021
  30. YANG Y, Long J, Wang C, Blot WJ, et al
    Prospective Study of Oral Microbiome and Gastric Cancer Risk Among Asian, African American and European American Populations.
    Int J Cancer. 2021 Oct 18. doi: 10.1002/ijc.33847.
    >> Share

    September 2021
  31. CABASAG CJ, Arnold M, Pineros M, Morgan E, et al
    Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2.
    Int J Cancer. 2021;149:1239-1246.
    >> Share

    August 2021
  32. KAWAI S, Wang C, Lin Y, Sasakabe T, et al
    Lifetime incidence risk for gastric cancer in the Helicobacter pylori-infected and uninfected population in Japan: A Monte Carlo simulation study.
    Int J Cancer. 2021 Aug 27. doi: 10.1002/ijc.33773.
    >> Share

    June 2021
  33. JAYASEKARA H, MacInnis RJ, Lujan-Barroso L, Mayen-Chacon AL, et al
    Lifetime alcohol intake, drinking patterns over time and risk of stomach cancer: A pooled analysis of data from two prospective cohort studies.
    Int J Cancer. 2021;148:2759-2773.
    >> Share

    May 2021
  34. HOFHEINZ RD, Hegewisch-Becker S, Kunzmann V, Thuss-Patience P, et al
    Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study G
    Int J Cancer. 2021 May 21. doi: 10.1002/ijc.33696.
    >> Share

  35. COLLATUZZO G, Pelucchi C, Negri E, Lopez-Carrillo L, et al
    Exploring the interactions between Hp infection and other risk factors of gastric cancer: a pooled analysis in the Stomach cancer Pooling (StoP) Project.
    Int J Cancer. 2021 May 14. doi: 10.1002/ijc.33678.
    >> Share

    April 2021
  36. NESS-JENSEN E, Bringeland EA, Mattsson F, Mjones P, et al
    Hypergastrinemia is associated with an increased risk of gastric adenocarcinoma with proximal location: A prospective population-based nested case-control study.
    Int J Cancer. 2021;148:1879-1886.
    >> Share

  37. LIU C, Song K, Hu Q, Hu C, et al
    Having gastroesophageal cancer is associated with increased risk of severe COVID-19-related events in patients with digestive tract cancer: A multicenter, retrospective, cohort study.
    Int J Cancer. 2021;148:1789-1793.
    >> Share

    January 2021
  38. WATANABE Y, Oikawa R, Kodaka Y, Sato Y, et al
    Cancer-related genetic variants of Helicobacter pylori strains determined using gastric wash-based whole-genome analysis with single-molecule real-time technology.
    Int J Cancer. 2021;148:178-192.
    >> Share

    December 2020
  39. KATAGIRI R, Goto A, Shimazu T, Yamaji T, et al
    Dietary fiber intake and risk of gastric cancer: the Japan Public Health Center-based prospective study.
    Int J Cancer. 2020 Dec 21. doi: 10.1002/ijc.33450.
    >> Share

  40. CHOI J, Jia G, Wen W, Long J, et al
    Evaluating polygenic risk scores in assessing risk of nine solid and hematologic cancers in European descendants.
    Int J Cancer. 2020;147:3416-3423.
    >> Share

  41. EL KHADIR M, Boukhris Alaoui S, Benajah DA, Ibrahimi SA, et al
    VacA genotypes and cagA-EPIYA-C motifs of Helicobacter pylori and gastric histopathological lesions.
    Int J Cancer. 2020;147:3206-3214.
    >> Share

    November 2020
  42. LI B, Cheung KS, Wong IY, Leung WK, et al
    Calcium channel blockers are associated with lower gastric cancer risk: a territory-wide study with propensity score analysis.
    Int J Cancer. 2020 Nov 5. doi: 10.1002/ijc.33379.
    >> Share

  43. CANZIAN F, Rizzato C, Obazee O, Stein A, et al
    Genetic polymorphisms in the cag pathogenicity island of Helicobacter pylori and risk of stomach cancer and high-grade premalignant gastric lesions.
    Int J Cancer. 2020;147:2437-2445.
    >> Share

  44. LORENZEN S, Knorrenschild JR, Pauligk C, Hegewisch-Becker S, et al
    Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC).
    Int J Cancer. 2020;147:2493-2502.
    >> Share

  45. GARCIA RODRIGUEZ LA, Soriano-Gabarro M, Vora P, Cea Soriano L, et al
    Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
    Int J Cancer. 2020;147:2394-2404.
    >> Share

    October 2020
  46. LV K, Li R, Cao Y, Gu Y, et al
    LAG-3 expression associates with poor prognosis and immunoevasive contexture in EBV-positive and MLH1-defective gastric cancer patients.
    Int J Cancer. 2020 Oct 26. doi: 10.1002/ijc.33358.
    >> Share

    August 2020
  47. CARIOLI G, Bertuccio P, Malvezzi M, Rodriguez T, et al
    Cancer mortality predictions for 2019 in Latin America.
    Int J Cancer. 2020;147:619-632.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016